BLRX
BioLineRx Ltd. American Depositary Shares (BLRX)
$49
About BioLineRx Ltd. American Depositary Shares (BLRX)
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
Details
Daily high
$0.49
Daily low
$0.45
Price at open
$0.47
52 Week High
$1.93
52 Week Low
$0.43
Market cap
39.0M
Dividend yield
0.00%
Volume
197,127
Avg. volume
320,618
P/E ratio
-1.07
BioLineRx Ltd. American Depositary Shares News
Details
Daily high
$0.49
Daily low
$0.45
Price at open
$0.47
52 Week High
$1.93
52 Week Low
$0.43
Market cap
39.0M
Dividend yield
0.00%
Volume
197,127
Avg. volume
320,618
P/E ratio
-1.07